Jupiter Neurosciences, Inc. (JUNS)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $2.20
- As of
Kresmion compiles this page from JUNS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
JUPITER NEUROSCIENCES, INC. (JUNS): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-03.
See the full JUNS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for JUNS on one page. Preview it with sample data, then open it live with a free account.
Preview the JUNS dossierActive events for JUNS
- lowEarnings below estimates
Q1-2025: EPS $-0.05 vs $-0.0306 estimate, -0.02 on a near-zero consensus
- mediumEarnings above estimates
Q3-2025: Beat consensus by 14.2% - EPS $-0.07 vs $-0.0816 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 6.2% - EPS $-0.067 vs $-0.0714 estimate
FREE, NO ACCOUNT
Every event on JUNS, as it fires
New filings, 13F moves and cross asset events on JUNS land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, JUNS
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
JUNS's 10-Q filed Aug 14, 2026 states:
In management's opinion, these conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of at least twelve months from the date of this report.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on JUNS
JUNS against its peers
JUNS's operating margin of -40873.2% ranks in the 6th percentile of 7 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-03-31.
| Metric | JUNS | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 21796 USD | 356500 USD | 28 | 8 |
| Gross margin | 80.6% | 77.6% | 58 | 5 |
| Operating margin | -40873.2% | -1601.2% | 6 | 7 |
| Net margin | -39662.8% | -1721.0% | 6 | 7 |
| Return on equity | n/a | -181.0% | n/a | 12 |
Peers (18): SILO, CMND, MBIO, KALA, LSBCF.D, DCOY, VSBC, CLDI, VIVS, ONCO, SXTP, EOCN, ERNA, BCAB, TRAW, ABPO, APVO, ACUT. Left out: NYMXF (period gap), VCNX (period gap), BIXT (no annual filing), NRSN (no annual filing), GPLL (period gap), AGNPF (no annual filing), LIMN (no annual filing). Fiscal periods ending between 2025-03-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (JUNS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in JUNS on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on JUNS in the last 180 days.
Upstream: SEC EDGAR filings for JUNS
Kresmion, "JUPITER NEUROSCIENCES, INC. (JUNS) institutional holdings and SEC filings", data as of 2026-09-03, https://kresmion.com/research/JUNS. Upstream data: SEC EDGAR filings for JUNS.
Link to this data (HTML):
<a href="https://kresmion.com/research/JUNS">JUPITER NEUROSCIENCES, INC. (JUNS) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow JUNS on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to JUNS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.